Greenrise Global Brands Inc. (XCX.CN)
CAD 0.02
(50.0%)
CAD 0.02
(50.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | - EUR | 0.0% |
| 2022 | - EUR | -100.0% |
| 2021 | 452.86 Thousand EUR | 330.48% |
| 2020 | 105.2 Thousand EUR | 0.0% |
| 2019 | - CAD | -100.0% |
| 2018 | 262.51 CAD | -14.09% |
| 2017 | 305.58 CAD | -98.09% |
| 2016 | 15.99 Thousand CAD | 749.25% |
| 2015 | 1883.78 CAD | -98.69% |
| 2014 | 143.79 Thousand CAD | 206.41% |
| 2013 | 46.93 Thousand CAD | 0.0% |
| 2012 | - CAD | -100.0% |
| 2011 | 23.35 Million CAD | -31.36% |
| 2010 | 34.02 Million CAD | -23.23% |
| 2009 | 44.32 Million CAD | 21.58% |
| 2008 | 36.45 Million CAD | 43.0% |
| 2007 | 25.49 Million CAD | 23.02% |
| 2006 | 20.72 Million CAD | -4.59% |
| 2005 | 21.72 Million CAD | 1.88% |
| 2004 | 21.32 Million CAD | 33.85% |
| 2003 | 15.92 Million CAD | 108.55% |
| 2002 | 7.63 Million CAD | 51.91% |
| 2001 | 5.02 Million CAD | 2.61% |
| 2000 | 4.9 Million CAD | 37.34% |
| 1999 | 3.56 Million CAD | 53.31% |
| 1998 | 2.32 Million CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | - EUR | 0.0% |
| 2024 Q1 | - EUR | 0.0% |
| 2023 Q3 | - EUR | 0.0% |
| 2023 Q1 | - EUR | 100.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2023 FY | - EUR | 0.0% |
| 2023 Q4 | - EUR | 0.0% |
| 2022 Q2 | 123.01 Thousand EUR | -15.43% |
| 2022 Q4 | -439.68 Thousand EUR | -356.82% |
| 2022 FY | - EUR | -100.0% |
| 2022 Q3 | 171.2 Thousand EUR | 39.17% |
| 2022 Q1 | 145.46 Thousand EUR | 44.81% |
| 2021 Q1 | 115.05 Thousand EUR | 9.37% |
| 2021 Q4 | 100.44 Thousand EUR | -12.61% |
| 2021 Q2 | 122.41 Thousand EUR | 6.4% |
| 2021 Q3 | 114.94 Thousand EUR | -6.1% |
| 2021 FY | 452.86 Thousand EUR | 330.48% |
| 2020 Q1 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 FY | 105.2 Thousand EUR | 0.0% |
| 2020 Q4 | 105.2 Thousand EUR | 63.11% |
| 2020 Q3 | 64.49 Thousand CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2019 Q2 | - CAD | -100.0% |
| 2019 Q1 | 88.70 CAD | -66.21% |
| 2019 FY | - CAD | -100.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2018 Q2 | 52.61 CAD | 10.21% |
| 2018 Q1 | 47.73 CAD | -68.55% |
| 2018 FY | 262.51 CAD | -14.09% |
| 2018 Q3 | - CAD | -100.0% |
| 2018 Q4 | 262.51 CAD | 0.0% |
| 2017 Q2 | 7.39 CAD | 163.41% |
| 2017 Q3 | 143.49 CAD | 1840.67% |
| 2017 Q1 | 2.81 CAD | -99.62% |
| 2017 FY | 305.58 CAD | -98.09% |
| 2017 Q4 | 151.79 CAD | 5.79% |
| 2016 Q4 | 743.94 CAD | 2051.59% |
| 2016 Q2 | 50.03 CAD | -99.67% |
| 2016 Q1 | 15.21 Thousand CAD | 6001.29% |
| 2016 FY | 15.99 Thousand CAD | 749.25% |
| 2016 Q3 | 34.58 CAD | -30.89% |
| 2015 Q1 | 826.70 CAD | -98.93% |
| 2015 Q4 | 249.31 CAD | -9.9% |
| 2015 Q3 | 276.71 CAD | -57.94% |
| 2015 Q2 | 657.92 CAD | -20.42% |
| 2015 FY | 1883.78 CAD | -98.69% |
| 2014 Q1 | 19.39 Thousand CAD | 112.19% |
| 2014 Q3 | 24.37 Thousand CAD | 17.92% |
| 2014 Q4 | 77.35 Thousand CAD | 217.3% |
| 2014 FY | 143.79 Thousand CAD | 206.41% |
| 2014 Q2 | 20.67 Thousand CAD | 6.57% |
| 2013 Q2 | 8455.22 CAD | -5.01% |
| 2013 FY | 46.93 Thousand CAD | 0.0% |
| 2013 Q1 | 8901.32 CAD | 0.0% |
| 2013 Q4 | -159.16 Thousand CAD | -184.01% |
| 2013 Q3 | 189.44 Thousand CAD | 2140.61% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | -100.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2012 Q1 | - CAD | -100.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2011 FY | 23.35 Million CAD | -31.36% |
| 2011 Q2 | 7.19 Million CAD | -18.89% |
| 2011 Q1 | 8.87 Million CAD | -15.59% |
| 2011 Q3 | 6.12 Million CAD | -14.9% |
| 2011 Q4 | 1.42 Million CAD | -76.72% |
| 2010 Q1 | 13.64 Million CAD | 4.87% |
| 2010 Q2 | 15.57 Million CAD | 14.12% |
| 2010 FY | 34.02 Million CAD | -23.23% |
| 2010 Q4 | 10.51 Million CAD | 45.84% |
| 2010 Q3 | 7.21 Million CAD | -53.71% |
| 2009 Q3 | 10.82 Million CAD | 1.42% |
| 2009 Q4 | 13.01 Million CAD | 20.21% |
| 2009 Q2 | 10.67 Million CAD | 21.83% |
| 2009 FY | 44.32 Million CAD | 21.58% |
| 2009 Q1 | 8.76 Million CAD | 41.96% |
| 2008 Q1 | 9.54 Million CAD | 38.85% |
| 2008 Q2 | 9.12 Million CAD | -4.42% |
| 2008 Q4 | 6.17 Million CAD | -38.87% |
| 2008 Q3 | 10.09 Million CAD | 10.64% |
| 2008 FY | 36.45 Million CAD | 43.0% |
| 2007 Q4 | 6.87 Million CAD | 26.98% |
| 2007 Q2 | 6.39 Million CAD | 3.83% |
| 2007 Q1 | 6.15 Million CAD | 72.99% |
| 2007 FY | 25.49 Million CAD | 23.02% |
| 2007 Q3 | 5.41 Million CAD | -15.34% |
| 2006 Q2 | 6.09 Million CAD | 10.17% |
| 2006 FY | 20.72 Million CAD | -4.59% |
| 2006 Q3 | 5.51 Million CAD | -9.56% |
| 2006 Q1 | 5.53 Million CAD | 287.64% |
| 2006 Q4 | 3.56 Million CAD | -35.45% |
| 2005 Q2 | 7.63 Million CAD | 10.73% |
| 2005 FY | 21.72 Million CAD | 1.88% |
| 2005 Q4 | -2.95 Million CAD | -133.36% |
| 2005 Q1 | 6.89 Million CAD | 16.37% |
| 2005 Q3 | 8.84 Million CAD | 15.81% |
| 2004 Q4 | 5.92 Million CAD | 26.19% |
| 2004 Q1 | 4.99 Million CAD | 59.87% |
| 2004 Q3 | 4.69 Million CAD | -23.96% |
| 2004 FY | 21.32 Million CAD | 33.85% |
| 2004 Q2 | 6.17 Million CAD | 23.56% |
| 2003 Q3 | 5.65 Million CAD | 24.27% |
| 2003 FY | 15.92 Million CAD | 108.55% |
| 2003 Q1 | 2.61 Million CAD | 105.04% |
| 2003 Q2 | 4.55 Million CAD | 73.87% |
| 2003 Q4 | 3.12 Million CAD | -44.76% |
| 2002 Q1 | 2.26 Million CAD | 63.52% |
| 2002 Q4 | 1.27 Million CAD | -47.39% |
| 2002 FY | 7.63 Million CAD | 51.91% |
| 2002 Q3 | 2.42 Million CAD | 21.14% |
| 2002 Q2 | 2 Million CAD | -11.36% |
| 2001 Q2 | 1.63 Million CAD | 110.74% |
| 2001 Q1 | 776.25 Thousand CAD | 248.12% |
| 2001 FY | 5.02 Million CAD | 2.61% |
| 2001 Q4 | 1.38 Million CAD | -3.6% |
| 2001 Q3 | 1.43 Million CAD | -12.31% |
| 2000 FY | 4.9 Million CAD | 37.34% |
| 2000 Q4 | 222.98 Thousand CAD | -80.14% |
| 2000 Q1 | 1.72 Million CAD | 108.42% |
| 2000 Q2 | 1.63 Million CAD | -5.7% |
| 2000 Q3 | 1.12 Million CAD | -31.13% |
| 1999 Q1 | 861.85 Thousand CAD | 0.0% |
| 1999 Q2 | 917.3 Thousand CAD | 6.43% |
| 1999 Q3 | 955.31 Thousand CAD | 4.14% |
| 1999 FY | 3.56 Million CAD | 53.31% |
| 1999 Q4 | 829.47 Thousand CAD | -13.17% |
| 1998 FY | 2.32 Million CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aion Therapeutic Inc. | 367.47 Thousand CAD | 100.0% |
| Ayurcann Holdings Corp. | 25.15 Million CAD | 100.0% |
| Blueberries Medical Corp. | 288.27 Thousand CAD | 100.0% |
| The BC Bud Corporation | 61.48 Thousand CAD | 100.0% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | 100.0% |
| CordovaCann Corp. | 13.59 Million CAD | 100.0% |
| Christina Lake Cannabis Corp. | 11.77 Million CAD | 100.0% |
| Captor Capital Corp. | 36.76 Million CAD | 100.0% |
| City View Green Holdings Inc. | 8582.00 CAD | 100.0% |
| 1CM Inc. | 35.34 Million CAD | 100.0% |
| Global Hemp Group Inc. | - CAD | NaN% |
| Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | 100.0% |
| IM Cannabis Corp. | 48.8 Million CAD | 100.0% |
| Lobe Sciences Ltd. | 840.53 Thousand CAD | 100.0% |
| Maple Leaf Green World Inc. | - CAD | NaN% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | 100.0% |
| Nextleaf Solutions Ltd. | 8.17 Million CAD | 100.0% |
| Ovation Science Inc. | 61.93 Thousand CAD | 100.0% |
| Pharmadrug Inc. | - CAD | NaN% |
| Captiva Verde Wellness Corp. | 174.78 Thousand CAD | 100.0% |
| RAMM Pharma Corp. | 5.06 Million CAD | 100.0% |
| RIV Capital Inc. | 7.48 Million CAD | 100.0% |
| Revive Therapeutics Ltd. | - CAD | NaN% |
| Red White & Bloom Brands Inc. | 88.33 Million CAD | 100.0% |
| SLANG Worldwide Inc. | 35.68 Million CAD | 100.0% |
| 1933 Industries Inc. | 18.27 Million CAD | 100.0% |
| Red Light Holland Corp. | 4.75 Million CAD | 100.0% |
| Top Strike Resources Corp. | 13.32 Million CAD | 100.0% |
| Xebra Brands Ltd. | 106.85 Thousand CAD | 100.0% |
| Adastra Holdings Ltd. | 22.22 Million CAD | 100.0% |